Table 2.
Assessment of responses (UICC)
Complete response (CR) | No measurable disease |
Partial response (PR) | Reduction of at least 50% in maximal dimension |
Objective response (OR) | CR or PR |
Stable disease (SD) | No change |
Progressive disease (PD) | Increase of at least 25% in maximal dimension, or new disease |
Clinical benefit (CB) | OR + SD at or beyond 6 months |
U/A | Unassessable |